drugset / Trial / NCT01363999
A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
A single-center, crossover study to evaluate the pharmacokinetics of dalcetrapib and atorvastatin from prototype fixed dose combination formulations in healthy volunteers. Volunteers will receive a single dose of dalcetrapib with atorvastatin in each of four treatment periods.
Timeline
- Start
- 2011-06
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | — | — |
| Subject | Dalcetrapib | Small molecule | — | — |
Indications
No indication recorded.